Ebola virus disease
New publisher/source coverage joined this story cluster: thehawk.in.
Source-first newsroom desks
Source-first desk
Agency updates, surveillance reports, travel notices, investigations, and official follow-up worth scanning directly.
New publisher/source coverage joined this story cluster: thehawk.in.
Outbreak News Today now includes deaths or fatal cases in the story frame.
PubMed Infectious Disease Search now explicitly uses investigation or monitoring language.
Cumulatively from weeks 1 to 19, the WHO AFR influenza laboratory network has tested 25,293 sentinel surveillance specimens for SARS-CoV-2, of which 785 were positive for SARS-CoV-2 (cumulative positivity rate 3.1%). SARS-CoV-2 In Epiweek 19, of the 908 specimens processed by 12 laboratories in the African Region, a total of 18 specimens tested positive for SARS-CoV-2 (positivity of 2%). The following influenza viruses were identified: Influenza A (H1N1)pdm09 (n = 4), Influenza A (H3) (n = 19), Influenza A (subtyping not performed) (n = 36), Influenza B (lineage not determined) (n = 3), and Influenza B (Victoria) (n = 24).
Recommendations and Reports / May 21, 2026 / 75(1);1â14 Nikhil Ranadive, MD 1 ,2 ,3 ; Joel L.N. Ridpath, MD 2 ( View author affiliations ) Guidance for Enhanced Investigation for Suspected Autochthonous Malaria Transmission During 2023, 10 cases of locally acquired mosquito-transmitted (autochthonous) malaria were reported to CDC from four U.S. states after a 20-year period with no autochthonous cases.
On 6 March 2026, the European Centre for Disease Prevention and Control (ECDC) launched a call for experts to join a new Scientific Expert Panel (SEP) to support the...
Guided by principles of professionalism, ethics, quality, innovation, equity, accountability, integrity, and affordability, the strategy focuses on six key priority areas: strengthening leadership and governance; enhancing human resources for oral health; improving the availability of commodities and equipment; expanding oral health promotion and disease prevention; upgrading oral healthcare services and infrastructure; and strengthening surveillance, monitoring, and research systems. Developed by the Ministry of Health in alignment with national health priorities and the WHO Global Strategy on Oral Health 2023–2030, the plan responds to the growing burden of oral diseases and builds on lessons and unfinished priorities from previous strategic plans. Implementation of the plan will be coordinated through national and sub-national health structures, supported by partnerships, resource mobilization, and routine monitoring and evaluation mechanisms.
In parallel, ECDC is in discussions with the European Civil Protection and Humanitarian Aid Operations and the Global Outbreak Alert and Response Network regarding the possible deployment of additional experts as the situation evolves, for example, in infection prevention, epidemiology, surveillance, and risk communication, to support response activities in DRC and Uganda. The European Centre for Disease Prevention and Control (ECDC) is deploying experts to support the response to the ongoing Ebola disease outbreak in the Democratic Republic of the Congo (DRC). They agreed on the details of collaboration, and ECDC will promptly deploy its experts to the region.
On 17 May 2026, the World Health Organization (WHO) declared the Ebola virus disease outbreak caused by Bundibugyo virus in the Democratic Republic of the Congo (DRC) a Public Health Emergency of International Concern.
* Statement updated to include new figures Eugene Kabambi Communications Officer WHO DRC Tel : +243 81 715 1697 Office : +47 241 39 027 Email: kabambie [at] who.int (kabambie[at]who[dot]int) Collins Boakye-Agyemang Communications and marketing officer Tel: + 242 06 520 65 65 (WhatsApp) Email: boakyeagyemangc [at] who.int (boakyeagyemangc[at]who[dot]int) carousel-bg The Bundibugyo species was first identified in 2007 in Bundibugyo district in western Uganda, during which 131 cases were reported with 42 deaths (case fatality rate of 32%). Laboratory analysis conducted by the National Institute of Biomedical Research (INRB), the country’s reference laboratory in the capital Kinshasa, confirmed the Ebola outbreak caused by the Bundibugyo species in 8 of 13 samples* collected from suspected cases linked to a cluster of severe illness and deaths reported in Mongbwalu and Rwampara health zones in Ituri Province.
Preliminary laboratory results indicate a non-Zaire ebolavirus species, with further analysis ongoing.
This report describes survey results from backyard flock owners' attitudes towards avian influenza.
This report describes an increase in dengue cases reported during 2024.
Only a brief source description was available at publication time.
Pathogen: Ebola viruses, including Bundibugyo virus in the current DRC/Uganda outbreak
Ebola remains a defining outbreak-desk disease because healthcare transmission, funeral practices, laboratory capacity, community trust, and international alarm can all move faster than the confirmed count.
Pathogen: Hantaviruses, including Andes virus in the Americas
This is a rare but frightening severe-disease story where a single unusual cluster can force questions about travel safety, rodent exposure, and whether Andes-virus-style person-to-person spread is in play.
Pathogen: Measles virus
Measles is a clean reporter desk disease because it reveals vaccination gaps, school and household spread, travel-linked importation, and public-health capacity all at once.
Pathogen: Bacillus anthracis
Anthrax is a strong local accountability story because livestock practices, slaughter exposure, and rural reporting gaps can hide serious outbreaks in plain sight.